Louis H. Stein

Dr. Louis H. Stein


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 December 2005 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AFAllison D. Fryer
Allison D. Fryer
LSLouis H. Stein
Louis H. Stein
ZNZhenying Nie
Zhenying Nie
DCDamian E. Curtis
Damian E. Curtis
CEChristopher M. Evans
Christopher M. Evans
DJDavid B. Jacoby
David B. Jacoby
Eosinophils cluster around airway nerves in patients with fatal asthma and in antigen-challenged animals. Activated eosinophils release major basic protein, which blocks inhibitory M2 muscarinic receptors (M2Rs) on nerves, increasing acetylcholine release and potentiating vagally mediated bronchoconstriction. We tested whether GW701897B, an antagonist of CCR3 (the receptor for eotaxin as well as a group of eosinophil active chemokines), affected vagal reactivity and M2R function in ovalbumin-challenged guinea pigs. Sensitized animals were treated with the CCR3 antagonist before inhaling ovalbumin. Antigen-challenged animals were hyperresponsive to vagal stimulation, but those that received the CCR3 antagonist were not. M2R function was lost in antigen-challenged animals, but not in those that received the CCR3 antagonist. Although the CCR3 antagonist did not decrease the number of eosinophils in lung tissues as assessed histologically, CCR3 antagonist prevented antigen-induced clustering of eosinophils along the nerves. Immunostaining revealed eotaxin in airway nerves and in cultured airway parasympathetic neurons from both guinea pigs and humans. Both IL-4 and IL-13 increased expression of eotaxin in cultured airway parasympathetic neurons as well as in human neuroblastoma cells. Thus, signaling via CCR3 mediates eosinophil recruitment to airway nerves and may be a prerequisite to blockade of inhibitory M2Rs by eosinophil major basic protein.

1 October 2013 in The American Journal of Cardiology
Verified
Journal Article
Closed access
LSLouis H. Stein
Louis H. Stein
JBJessica Berger
Jessica Berger
MTMaryann Tranquilli
Maryann Tranquilli
JEJohn A. Elefteraides
John A. Elefteraides

19 January 2012 in Journal of Gastrointestinal Surgery
Verified
Journal Article
Closed access
PDF file
LRLaura H. Rosenberger
Laura H. Rosenberger
LSLouis H. Stein
Louis H. Stein
AWAgnieszka K. Witkiewicz
Agnieszka K. Witkiewicz
EKEugene P. Kennedy
Eugene P. Kennedy
CYCharles J. Yeo
Charles J. Yeo

8 March 2022 in Polymers
Verified
Journal Article
Open access
PDF file
ZWZhiqian Wang
Zhiqian Wang
Sumona PaulSumona Paul
Sumona Paul
LSLouis H. Stein
Louis H. Stein
ASArash Salemi
Arash Salemi
Somenath MitraSomenath Mitra
Somenath Mitra
Superhydrophobic surfaces, as indicated in the name, are highly hydrophobic and readily repel water. With contact angles greater than 150° and sliding angles less than 10°, water droplets flow easily and hardly wet these surfaces. Superhydrophobic materials and coatings have been drawing increasing attention in medical fields, especially on account of their promising applications in blood-contacting devices. Superhydrophobicity controls the interactions of cells with the surfaces and facilitates the flowing of blood or plasma without damaging blood cells. The antibiofouling effect of superhydrophobic surfaces resists adhesion of organic substances, including blood components and microorganisms. These attributes are critical to medical applications such as filter membranes, prosthetic heart valves, extracorporeal circuit tubing, and indwelling catheters. Researchers have developed various methods to fabricate blood-compatible or biocompatible superhydrophobic surfaces using different materials. In addition to being hydrophobic, these surfaces can also be antihemolytic, antithrombotic, antibacterial, and antibiofouling, making them ideal for clinical applications. In this review, the authors summarize recent developments of blood-compatible superhydrophobic surfaces, with a focus on methods and materials. The expectation of this review is that it will support the biomedical research field by providing current trends as well as future directions.

1 April 2010 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
LSLouis H. Stein
Louis H. Stein
JEJohn A. Elefteriades
John A. Elefteriades

5 August 2009 in Journal of Innate Immunity
Verified
Journal Article
Closed access
PDF file
LSLouis H. Stein
Louis H. Stein
KRKevin M. Redding
Kevin M. Redding
JLJames J. Lee
James J. Lee
TNThomas J. Nolan
Thomas J. Nolan
GSGerhard A. Schad
Gerhard A. Schad
DADavid Abraham
David Abraham
Protective innate immunity to the nematode Strongyloides stercoralis requires eosinophils in the parasite killing process. Experiments were performed to determine if an extract of S. stercoralis would trigger eosinophil chemotaxis, and to then compare the chemotactic migration response, including second messenger signals and receptors, to those mechanisms triggered by host chemoattractants. Eosinophils undergo both chemotaxis and chemokinesis to soluble parasite extract in transwell plates. Pretreatment of eosinophils with pertussis toxin, a G protein-coupled receptor inhibitor, inhibited migration of the eosinophils to the parasite extract. Likewise, blocking PI3K, tyrosine kinase, p38 and p44/42 inhibited eosinophil chemotaxis to parasite extract. Furthermore, CCR3, CXCR4 or CXCR2 antagonists significantly inhibited eosinophil chemotaxis to the parasite extract. Molecular weight fractionation of parasite extract revealed that molecules attracting eosinophils were present in several fractions, with molecules greater than 30 kDa being the most potent. Treating the extract with proteinase K or chitinase significantly inhibited its ability to induce chemotaxis, thereby demonstrating that the chemoattractants were both protein and chitin. Therefore, chemoattractants derived from parasites and host species stimulate similar receptors and second messenger signals to induce eosinophil chemotaxis. Parasite extract stimulates multiple receptors on the eosinophil surface, which ensures a robust innate immune response to the parasite.